Bedtime VLD CBP treatment improved core FM symptoms.
Nights with CAP(A2+A3(Norm)) ≤ 33% may provide a biomarker for assessing treatment effects on nonrestorative sleep and associated fatigue and mood symptoms in persons with FM.
2011-12-02
Eng.
The Journal of rheumatology
Sleep Disorders Clinics, Centre for Sleep and Chronobiology, University of Toronto, Toronto, Ontario, Canada. h.moldofsky [at] utoronto.ca
J Rheumatol. 2011 Dec;38(12):2653-63
© Galenicom 1999-2013